The salvage chemotherapy for refractory testicular cancer with novel anticancer agents
Despite the generally high cure rate in patients with metastatic testicular cancer, 20% to 30% of treated patients will become candidates for salvage chemotherapy. We reviewed the recent salvage chemotherapy trials of refractory diseases. CPT-11 is a new derivative of camptothecin and has activity i...
| Publié dans: | Hinyokika kiyo. Acta urologica Japonica. - 1962. - 45(1999), 11 vom: 23. Nov., Seite 811-4 |
|---|---|
| Auteur principal: | |
| Autres auteurs: | , , , , , , |
| Format: | Article |
| Langue: | Japanese |
| Publié: |
1999
|
| Accès à la collection: | Hinyokika kiyo. Acta urologica Japonica |
| Sujets: | Clinical Trial Journal Article Antineoplastic Agents, Phytogenic Organoplatinum Compounds Irinotecan 7673326042 nedaplatin 8UQ3W6JXAN Cisplatin Q20Q21Q62J plus... |